Pioneering the Future of Pharmaceutical Innovation

Copenhagen-based Biopharmaceutical Company

Tetra Pharm Technologies is a Danish biopharmaceutical company that specializes in the development of pharmaceutical drugs aimed at the central nervous system and the immune system to treat neurological diseases and mental health disorders.

In addition to a strong R&D pipeline, Tetra Pharm Technologies offers a suite of tailored end-to-end CDMO services that leverages the company's proprietary drug delivery technology, ZYNDIKATE®.

  • Scientific Approach

    Scientific Approach

    We advance CNS therapies through neuroscience and delivery innovation - bridging research, impact, and scalability from molecule to market

    Learn more
  • R&D Pipeline

    R&D Pipeline

    At present, we have multiple formulations intended for obesity (with neurological focus), chronic pain and mental health disorders in our clinical pipeline.

    Learn more

  • Improving Quality of Life Through Science

    Tetra Pharm Technologies specializes in the development of pharmaceutical drugs aimed at the central nervous system (CNS) and the immune system to treat neurological diseases and mental health disorders.

    Learn more

  • Science at the Forefront

    Science drives everything Tetra Pharm Technologies does as we continue to address unmet needs within neurological diseases and mental health disorders targeting the Central Nervous System (CNS)

    Learn more

  • Conscious About Our Role in Society

    We are dedicated to operating as a sustainable business and are committed to making a positive impact on the world around us.

    Learn more

  • News

    Keep updated on all the latest news and press releases from Tetra Pharm Technologies

    learn more